Logo do repositório
 
Publicação

Mechanisms underlying the physiological role of amyloid precursor protein glutamatergic synapses

datacite.subject.fosCiências Médicas::Ciências da Saúdept_PT
dc.contributor.advisorLopes, Luísa Maria Vaqueiro
dc.contributor.advisorPousinha, Paula Antunes
dc.contributor.authorRajão-Saraiva, Joana
dc.date.accessioned2024-05-24T11:04:34Z
dc.date.available2024-05-24T11:04:34Z
dc.date.issued2023-07
dc.date.submitted2023-05
dc.description.abstractN-methyl-D-aspartate receptors (NMDARs) are glutamatergic ionotropic receptors essential for synaptic maturation during development and synaptic plasticity in adult stages, whose properties are known to change depending on the life stage. In particular, the subunit composition of synaptic NMDARs has important implications for NMDAR function. In the hippocampus, NMDARs are mainly composed by GluN2A or GluN2B subunits, with GluN2B-NMDARs being associated with slower kinetics, more calcium charge transfer and higher mobility. GluN2B-NMDARs are predominant in immature synapses during development, contributing to the synaptic maturation process, which involves a GluN2B to GluN2A shift. Thus, GluN2A-NMDARs are the most abundant subtype in adult stages, when most synapses are in the mature state. Much less is known about the subunit contribution in aged synapses. However, previous reports showed age-related alterations in NMDAR properties, such as slower responses, lower current amplitudes and a negative correlation between GluN2B levels and memory performance. These alterations in NMDAR properties, from development to aging, might be caused by different regulation mechanisms. The amyloid precursor protein (APP), which is mainly known to be involved in Alzheimer’s Disease, has emerged as a putative regulator of NMDARs. Although the physiological role of APP is not fully understood, it is known to regulate synaptogenesis and synaptic plasticity and might have different effects when acting through the full-length protein or its derived fragments. Additionally, APP has shown to interact and regulate NMDAR surface levels and currents but the functional relevance of this interaction at different life stages, as well as the underlying mechanisms of regulation have not been explored so far. Thus, we hypothesized that APP regulates NMDARs in an age-dependent manner and defined as the main aims of this work to study APP-NMDAR regulation mechanisms in immature, mature and aged synapses. To address these questions in physiological conditions, we used as our experimental models the hippocampus of wild-type C57Bl/6 mice at different life stages (infant (7-10 days), adults (10-16 weeks) and aged (18 – 20 months), as well as postmortem brain tissue from human subjects with different ages (18-89 years old) and rodent hippocampal primary neuronal cultures. By combining patch-clamp electrophysiology and molecular approaches, we have unraveled a dual mechanism by which APP controls GluN2B-NMDARs, depending on the life stage. In the present study, we show that APP is highly abundant at the post synapse in infant mice, where it interacts with GluN2B-NMDARs, controlling its mediated currents. Moreover, APP knockdown in primary neuronal cultures caused a reduction in GluN2B-NMDAR synaptic content, suggesting that APP might be important to stabilize the receptors at the synapse. Considering the crucial role of GluN2B-NMDAR in synapse maturation, this mechanism might potentially be important to achieve functional, mature synapses during development. Although this interaction is maintained in adult/aged synapses, NMDAR-mediated currents showed to be unaltered when interfering with the APP C-terminal during a short period at these ages, contrary to the results obtained in infant mice. Thus, we concluded that the APP-NMDAR regulatory mechanisms are different in adult/aged mice when compared to infants. We hypothesize that alterations in the APP-NMDAR regulation could be the underlying mechanism for age-related alterations in NMDAR properties. Accordingly, we found that aged mice exhibit an increase in GluN2B-NMDAR relative currents, which does not correlate with alterations in subunit levels. Moreover, we found an increase in APP processing into intracellular fragments upon aging. Importantly, when we inhibited APP processing or interfered with APP intracellular signaling in aged mice, we were able to normalize GluN2B-NMDAR synaptic contribution to adult-like levels. Thus, we propose that signaling pathways mediated by APP intracellular fragments induce an increase in GluN2B-NMDAR relative currents upon aging. Additionally, we show that APP processing into intracellular fragments also tends to increase in aged humans, suggesting that a similar mechanism might occur in mice and humans. Considering the impact of NMDAR on synaptic plasticity, this increase in GluN2B-NMDAR relative currents can potentially contribute to age-related synaptic and memory impairments.pt_PT
dc.description.sponsorshipSanta Casa da Misericórdia (MB-7-2018)pt_PT
dc.identifier.tid101673213pt_PT
dc.identifier.urihttp://hdl.handle.net/10451/64860
dc.language.isoengpt_PT
dc.relationMechanisms underlying the physiological role of APP in glutamatergic synapses
dc.relationMechanisms underlying the physiological role of APP in glutamatergic synapses
dc.subjectPPA (proteína precursora de amiloide)pt_PT
dc.subjectrecetor NMDApt_PT
dc.subjectenvelhecimentopt_PT
dc.subjectdesenvolvimento pós-natalpt_PT
dc.subjectsinapse glutamatérgicapt_PT
dc.subjectAPP (amyloid precursor protein)pt_PT
dc.subjectNMDA receptorpt_PT
dc.subjectagingpt_PT
dc.subjectpostnatal developmentpt_PT
dc.subjectglutamatergic synapsept_PT
dc.titleMechanisms underlying the physiological role of amyloid precursor protein glutamatergic synapsespt_PT
dc.typedoctoral thesis
dspace.entity.typePublication
oaire.awardNumberPD/BD/135516/2018
oaire.awardNumberCOVID/BD/152606/2022
oaire.awardTitleMechanisms underlying the physiological role of APP in glutamatergic synapses
oaire.awardTitleMechanisms underlying the physiological role of APP in glutamatergic synapses
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/OE/PD%2FBD%2F135516%2F2018/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/OE/COVID%2FBD%2F152606%2F2022/PT
oaire.fundingStreamOE
oaire.fundingStreamOE
person.familyNameRajão-Saraiva
person.givenNameJoana
person.identifier.orcid0000-0003-0970-8665
person.identifier.scopus-author-id57211134392
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typedoctoralThesispt_PT
relation.isAuthorOfPublicationa6a615f8-f1f9-4518-a6d3-1c0c8bad7b8c
relation.isAuthorOfPublication.latestForDiscoverya6a615f8-f1f9-4518-a6d3-1c0c8bad7b8c
relation.isProjectOfPublication7a500aa6-cea5-4db5-83a8-e3ff648c386b
relation.isProjectOfPublicationac5b99d1-521f-450c-961d-241b0e6482f8
relation.isProjectOfPublication.latestForDiscoveryac5b99d1-521f-450c-961d-241b0e6482f8
thesis.degree.nameTese de doutoramento, Ciências Biomédicas (Neurociências), Universidade de Lisboa, Faculdade de Medicina, 2023pt_PT

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
scnd990026354741638_td_Joana_Saraiva.pdf
Tamanho:
14.77 MB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: